Proteomics investigates biomarkers for mesothelioma
Filed with ASX · · 2 pages · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Proteomics expands diagnostics portfolio to endometriosis
- Proteomics first commercialisation deal for PromarkerD
- Appendix 4C - June 2016 Quarterly Report
- PromarkerD Development Advances in China
Later from Proteomics International Laboratories
- Proteomics International receives FY16 R&D Tax Incentive
- Proteomics targets gastro-causing parasite
- Appendix 4C - September 2016 Quarterly Report
- PromarkerD test kit production deal signed
- Proteomics and Linear partner in testing and clinical trials
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories